Clinical trial for Colorectal Cancer
Official title Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
ClinicalTrials.gov ID: NCT04767568
What this study is testing
- What it's testing
- Colorectal cancer (CRC) is the third most common cancer in men and the second in women with an incidence of 43,350 new cases in 2018. This incidence is increasing every year.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged more than18 years
- Cohort A : patients with suspected colorectal cancer following a positive immunological test during screening (presence of blood detected in the...
- Signed and dated informed consent
- Patient affiliated to or beneficiary of French social security system.
You likely can't join if
- Vulnerable persons according to the law (minors, adults under protection, persons deprived of liberty ...)
- Not ability to comply with the study protocol, in the Investigator's judgment
- pregnant woman
- Patient in the period of exclusion of another study
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
- Montbéliard, France
- Vesoul, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France; Montbéliard, France; Vesoul, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.